ScoreWhy is Shukra Pharmaceuticals Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.05 times
2
Healthy long term growth as Operating profit has grown by an annual rate 58.49%
3
Flat results in Sep 25
- NET SALES(Q) At Rs 5.88 cr has Fallen at -32.4% (vs previous 4Q average)
- PBDIT(Q) Lowest at Rs -0.42 cr.
- OPERATING PROFIT TO NET SALES (Q) Lowest at -7.14%
4
With ROE of 18.2, it has a Very Expensive valuation with a 26.7 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 542.08%, its profits have fallen by -17.2%
5
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
6
Consistent Returns over the last 3 years
- Along with generating 542.08% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shukra Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shukra Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Shukra Pharma.
542.08%
12.12
44.71%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
26.81%
EBIT Growth (5y)
58.49%
EBIT to Interest (avg)
5.71
Debt to EBITDA (avg)
0.66
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.85
Tax Ratio
9.60%
Dividend Payout Ratio
4.57%
Pledged Shares
0
Institutional Holding
0.11%
ROCE (avg)
11.39%
ROE (avg)
14.72%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
147
Industry P/E
34
Price to Book Value
26.70
EV to EBIT
195.92
EV to EBITDA
143.72
EV to Capital Employed
31.09
EV to Sales
49.76
PEG Ratio
NA
Dividend Yield
0.02%
ROCE (Latest)
15.87%
ROE (Latest)
18.17%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
OPERATING CF(Y)
Highest at Rs 7.92 Cr
NET SALES(9M)
At Rs 24.54 cr has Grown at 25.08%
PAT(9M)
Higher at Rs 8.80 Cr
-11What is not working for the Company
NET SALES(Q)
At Rs 5.88 cr has Fallen at -32.4% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs -0.42 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at -7.14%
PBT LESS OI(Q)
Lowest at Rs -1.51 cr.
PAT(Q)
At Rs 2.38 cr has Fallen at -5.9% (vs previous 4Q average
NON-OPERATING INCOME(Q)
is 855.00 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Shukra Pharma.
Operating Cash Flow - Annually
Highest at Rs 7.92 Cr
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Here's what is not working for Shukra Pharma.
Net Sales - Quarterly
At Rs 5.88 cr has Fallen at -32.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 8.70 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.51 cr has Fallen at -165.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 2.32 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.42 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at -7.14%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -1.51 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 2.38 cr has Fallen at -5.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.53 CrMOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
Non Operating Income - Quarterly
is 855.00 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Non Operating Income - Quarterly
Highest at Rs 1.71 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
